Repositorio Dspace

Listar por tema "SARS-CoV-2/immunology"

Listar por tema "SARS-CoV-2/immunology"

Ordenar por:Orden:Resultados:

  • Delaunay, Charlotte-Laniece; Verdasca, Nuno; Monge, Susana; Domegan, Lisa; Seve, Noemie; Buda, Silke; Meijer, Adam; Lucaccioni, Heloise; López-Torrijos, Miriam; Mckenna, Adele; Enouf, Vincent; Duerrwald, Ralf; In't-Velt, Eline; de-Valcárcel-Laiglesia, Ma-Angel; Bennett, Charlene; Masse, Shirley; Erdwiens, Annika; Hooiveld, Mariette; Mlinaric, Ivan; Turi, Gergo; Rodrigues, Ana-Paula; Martínez-Baz, Iván; Lazar, Mihaela; Latorre-Margalef, Neus; Borges, Vitor; Kaczmarek, Marlena; Bacci, Sabrina; Kissling, Esther; European-Primary-Care-VE-Group (WILEY, 2025-05)
    We estimated the effectiveness of 2024/25 COVID-19 vaccination against medically attended SARS-CoV-2 infection in Europe, among target groups. We included 3204 patients (8/139 cases vaccinated: 6%; 517/3065 controls ...
  • Rojas-Benedicto, Ayelen; Perez-Gimeno, Gloria; Mendioroz, Jacobo; Corral, Irene Pedrosa; Torrijos, Miriam Lopez; Rumayor, Mercedes; Lopez, Ma Angeles Rafael de la Cruz; Wagner, Eva Rivas; de Laiglesia, Ma Angel Valcarcel; Canete, Ines Guiu; Ibanez, Ana Fernandez; Martinez, Olaia Perez; Dopido, Juan Antonio Linares; Latasa, Pello; Torres-Juan, Marta; Recio, Ma Jesus Rodriguez; Castrillejo, Daniel; Raymundo, Luis Javier Viloria; Berrios, Ninoska Lopez; Vazquez-Moron, Sonia; Monge, Susana (TAYLOR & FRANCIS LTD, 2025-12-31)
    BACKGROUND: We estimated vaccine effectiveness (VE) of the COVID-19 monovalent XBB.1.5 vaccine recommended in Spain in October 2023 for ?60-year-olds against medically attended COVID-19 and COVID-19 hospitalization, during ...
  • Pons-Fuster, Eduardo; Martínez-Rodríguez, Rodrigo; Gimeno-Arias, Lourdes; Alcaraz, M-J; Moreno, Marta; Gómez, José-M; Peláez-Ballesta, Ana-Isabel; García, Elisa; Tomas, Cristina; Muñoz, Ángeles; V; Ruiz-Lorente, Inmaculada; Ceballos, Diana; Minguela-Puras, Alfredo; Bernal-Morell, Enrique (ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2025-06)
    BACKGROUND: The COVID-19 pandemic has led to widespread infection, with a significant subset of patients developing persistent symptoms known as Long COVID. Understanding the genetic factors influencing Long COVID ...